Cargando…

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”

Detalles Bibliográficos
Autor principal:	Lee, Hye Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845673/ https://www.ncbi.nlm.nih.gov/pubmed/36353764 http://dx.doi.org/10.3350/cmh.2022.0384

Ejemplares similares

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Jeong, Seogsong, et al.
Publicado: (2023)

The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults
por: Lee, Jun-Hyuk, et al.
Publicado: (2022)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Lee, Jun-Hyuk, et al.
Publicado: (2022)

Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Lee, Seung Min, et al.
Publicado: (2023)

Letter regarding “Evidence-based hyponatremia management in liver disease”
por: Theodorou, Daphne J., et al.
Publicado: (2023)

Letter regarding “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Luo, Meng-Si, et al.
Publicado: (2021)

Response to letter to editor regarding ECEIM consensus statement on equine metabolic syndrome
por: Durham, Andy E., et al.
Publicado: (2019)

Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Liu, Yuanbin, et al.
Publicado: (2023)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Han, Seul Ki, et al.
Publicado: (2023)

Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)

Letter regarding the article “Lumbar opening pressure and radiologic scoring in idiopathic intracranial hypertension: is there any correlation?”
por: Onder, Halil
Publicado: (2018)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
por: Emiroglu, Halil Haldun
Publicado: (2023)

Regarding the letter from Roxburgh, et al.
por: Gross, RH, et al.
Publicado: (2020)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Letter to the Editor regarding “Can early cranioplasty reduce the incidence of hydrocephalus after decompressive craniectomy? A meta-analysis”
por: Goedemans, Taco, et al.
Publicado: (2020)

Letter to the Editor in regard to the “Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome” by Roedl et al.”
por: Krieg, A. D., et al.
Publicado: (2021)

Letter to the Editor regarding “incidence of traumatic spinal cord injury worldwide: A systematic review, data integration, and update”
por: Finsterer, Josef
Publicado: (2023)

Answer to the letter “TyG in insulin resistance prediction”()
por: Vieira-Ribeiro, Sarah A., et al.
Publicado: (2019)

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Hong, Jian-Guo, et al.
Publicado: (2022)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Letter regarding “ACVIM consensus statement on pancreatitis in cats”
por: Kook, Peter, et al.
Publicado: (2021)

Letter regarding "ACVIM consensus statement on pancreatitis in cats"
por: Törner, Katrin, et al.
Publicado: (2021)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
por: Boudier-Revéret, Mathieu, et al.
Publicado: (2022)

Letter to the editor regarding “Selfies: A boon or bane?”
por: Kazerooni, Rashid
Publicado: (2022)

Letter to the Editor Regarding: Evolving Business Models in Orthotics
por: Laakso, L.
Publicado: (2022)

Letter to the editor regarding “unusual extraneural metastasis of glioblastoma”
por: Waack, Andrew Leland, et al.
Publicado: (2023)

Letter to Editor regarding “Unusual Presentation of Spontaneous Chylothorax”
por: Varghese, Anjali Rachel, et al.
Publicado: (2022)

Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Yoon, Eileen L., et al.
Publicado: (2023)

Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
por: Jeong, Seogsong, et al.
Publicado: (2022)

Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Cheung, Ka Shing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m2pnmegjir39okt55r8p32plpj